J 2017

The joint EPUAP & EWMA pressure ulcer prevention & patient safety advocacy project

MOORE, Z., J.V. SORIANO, Andrea POKORNÁ, L. SCHOONHOVEN, H. VUAGNAT et. al.

Basic information

Original name

The joint EPUAP & EWMA pressure ulcer prevention & patient safety advocacy project

Authors

MOORE, Z. (372 Ireland), J.V. SORIANO (724 Spain), Andrea POKORNÁ (203 Czech Republic, guarantor, belonging to the institution), L. SCHOONHOVEN (840 United States of America), H. VUAGNAT (756 Switzerland), A. MARKOVA (826 United Kingdom of Great Britain and Northern Ireland) and J. KRISTENSEN (826 United Kingdom of Great Britain and Northern Ireland)

Edition

Wounds UK, London, Wounds UK Ltd. 2017, 1746-6814

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30307 Nursing

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/17:00098409

Organization unit

Faculty of Medicine

Keywords in English

EPUAP; EWMA; Key performance indicator; Patient safety; Pressure ulcer

Tags

Tags

International impact, Reviewed
Změněno: 22/3/2018 15:47, Soňa Böhmová

Abstract

V originále

Background: Pressure ulcers (PUs) are a common, costly, debilitating problem across all healthcare sectors, despite significant investment in education and training and use of human resources, equipment, and technological advancements. In recognising the persistent problem of PUs, the European Wound Management Association (EWMA) and the European Pressure Ulcer Advisory Panel (EPUAP) have created a group to work collectively on a specific project advocating for the prevention of PUs to be considered as a major health care and patient safety issue. Aim: The overall aim of the project is to establish a joint EPUAP-EWMA working group on PU prevention and engage in patient safety agendas at the European level as well as at the national level in selected European countries. Discussion: We are seeking to place prevention of PUs as a high priority on the patient safety agenda within the European Union (EU). To achieve this, given the lack of agreed methodology for incidence monitoring, we advocate for the use of standardised monitoring of PU prevalence, with targeted prevention measures to reduce prevalence, made available across the continuum of care. Conclusion: Adopting PU prevalence as a key measurement tool across the wider health care sector in the EU, will ensure that both adequate monitoring of prevalence and use of prevention can be achieved.